The Effect of Sifrol® on Tremor and Depression in Patients With Idiopathic Parkinson's Disease
The Effect of Sifrol® on Tremor and Depression in Patients With Idiopathic Parkinson's Disease
Documentation of the effect of SIFROL® on tremor and depression as well as its tolerability
 in ambulatory patients suffering from idiopathic Parkinson's disease under routine conditions
Inclusion Criteria:

 -  Patients with idiopathic Parkinson's disease with tremor and/or depression requiring
 therapy with Sifrol® or change of therapy to Sifro®l and not under medication with
 neuroleptics were allowed to be observed during the study

 Exclusion Criteria:

 -  Patients who meet one or more of the general or specific contraindications mentioned
 in the Summary of Product Characteristics (SPC) for Sifrol®

 -  Patients under treatment with neuroleptics should not be observed during this study